{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T15:08:39Z","timestamp":1782140919220,"version":"3.54.5"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.urology.2020.06.023","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T19:29:13Z","timestamp":1593545353000},"page":"124-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Sacral Neuromodulation: Determining Predictors of Success"],"prefix":"10.1016","volume":"153","author":[{"given":"Tara Nikonow","family":"Morgan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Pace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Mohapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianxu","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Kunkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Tennyson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan P.","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Chermansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2020.06.023_bib0001","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11884-016-0344-9","article-title":"The burden of overactive bladder on US public health","volume":"11","author":"Reynolds","year":"2016","journal-title":"Curr Bladder Dysfunct Rep"},{"key":"10.1016\/j.urology.2020.06.023_bib0002","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.juro.2017.07.010","article-title":"Five-year followup results of a prospective, multicenter study of patients with overactive bladder treated with sacral neuromodulation","volume":"199","author":"Siegel","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2020.06.023_bib0003","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.eururo.2018.02.011","article-title":"Two-year outcomes of sacral neuromodulation versus onabotulinumtoxinA for refractory urgency urinary incontinence: a randomized trial","volume":"74","author":"Amundsen","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2020.06.023_bib0004","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1002\/nau.23596","article-title":"International continence society best practice statement for use of sacral neuromodulation","volume":"37","author":"Goldman","year":"2018","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2020.06.023_bib0005","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/SPV.0b013e31828ab3c9","article-title":"Reoperation after sacral neuromodulation therapy: a single-institution experience","volume":"19","author":"Shih","year":"2013","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"10.1016\/j.urology.2020.06.023_bib0006","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.juro.2010.10.054","article-title":"Long-term outcome and surgical interventions after sacral neuromodulation implant for lower urinary tract symptoms: 14-year experience at 1 center","volume":"185","author":"Al-zahrani","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2020.06.023_bib0007","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/ner.12649","article-title":"Optimal lead positioning in sacral neuromodulation: which factors are related to treatment outcome?","volume":"20","author":"Jairam","year":"2017","journal-title":"Neuromodulation"},{"key":"10.1016\/j.urology.2020.06.023_bib0008","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/nau.22766","article-title":"Number of active electrodes at time of staged tined lead interstim implant does not impact clinical outcomes","volume":"35","author":"Gilleran","year":"2016","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2020.06.023_bib0009","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.juro.2017.11.066","article-title":"Motor response matters: optimizing lead placement improves sacral neuromodulation outcomes","volume":"199","author":"Pizarro-Berdichevsky","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2020.06.023_bib0010","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/j.juro.2012.01.123","article-title":"Randomized multicenter clinical trial of myofascial physical therapy in women with interstitial cystitis\/painful bladder syndrome and pelvic floor tenderness","volume":"187","author":"FitzGerald","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2020.06.023_bib0011","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.urology.2012.11.073","article-title":"Clinical outcomes of sacral neuromodulation in patients with neurologic conditions","volume":"81","author":"Peters","year":"2013","journal-title":"Urology"},{"key":"10.1016\/j.urology.2020.06.023_bib0012","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.eururo.2010.09.024","article-title":"Sacral neuromodulation for neurogenic lower urinary tract dysfunction: systematic review and meta-analysis","volume":"58","author":"Kessler","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2020.06.023_bib0013","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/ner.12213","article-title":"Proof of concept trial on changes in current perception threshold after sacral neuromodulation","volume":"18","author":"Wenzler","year":"2015","journal-title":"Neuromodulation"},{"key":"10.1016\/j.urology.2020.06.023_bib0014","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/nau.22929","article-title":"Predictors of reoperation after sacral neuromodulation: a single institution evaluation of over 400 patients","volume":"36","author":"Peters","year":"2017","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2020.06.023_bib0015","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s00192-011-1512-2","article-title":"Determining outcomes, adverse events, and predictors of success after sacral neuromodulation for lower urinary disorders in women","volume":"22","author":"Yazdany","year":"2011","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.urology.2020.06.023_bib0016","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/SPV.0b013e31826150fe","article-title":"Does obesity impact the success of an InterStim test phase for the treatment of refractory urge urinary incontinence in female patients?","volume":"18","author":"Levin","year":"2012","journal-title":"Female Pelvic Med Reconstruct Surg"},{"key":"10.1016\/j.urology.2020.06.023_bib0017","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.juro.2017.01.037","article-title":"Urinary biomarkers in women with refractory urgency urinary incontinence randomized to sacral neuromodulation versus onabotulinumtoxinA compared to controls","volume":"197","author":"Richter","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2020.06.023_bib0018","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/nau.22437","article-title":"Randomized prospective crossover study of interstim lead wire placement with curved versus straight stylet","volume":"33","author":"Jacobs","year":"2014","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2020.06.023_bib0019","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/bju.14240","article-title":"Improving clinical outcomes for women with overactive bladder or urinary retention symptoms: a comparison of motor response voltages (1-9 V) during Stage 1 sacral neuromodulation","volume":"122","author":"Marinkovic","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2020.06.023_bib0020","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.urology.2016.06.004","article-title":"Sacral neuromodulation in urological practice","volume":"99","author":"Liberman","year":"2017","journal-title":"Urology"},{"key":"10.1016\/j.urology.2020.06.023_bib0021","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/nau.23117","article-title":"Sacral neuromodulation for refractory overactive bladder after prior intravesical onabotulinumtoxinA treatment","volume":"36","author":"Hoag","year":"2017","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2020.06.023_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.juro.2013.07.017","article-title":"Sacral neuromodulation in patients with idiopathic overactive bladder after initial botulinum toxin therapy","volume":"190","author":"Smits","year":"2013","journal-title":"J Urol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429520307780?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429520307780?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T02:35:36Z","timestamp":1758767736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429520307780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":22,"alternative-id":["S0090429520307780"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2020.06.023","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sacral Neuromodulation: Determining Predictors of Success","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2020.06.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}